Last updated: August 12, 2025
Introduction
Patent KR20070089687 relates to a pharmaceutical invention filed in South Korea, which covers a specific drug composition or formulation, its method of use, or manufacturing process. Understanding the patent's scope, claims, and landscape is critical for pharmaceutical companies to navigate licensing, infringement risks, and R&D innovation. This analysis aims to provide a comprehensive review of the patent's coverage, its claims, and how it fits within the broader patent environment in the pharmaceutical field.
1. Patent Overview and Classification
KR20070089687 was filed in South Korea, likely around 2007, and is primarily examined through the lens of its claims and legal status. Based on the typical structure, the patent encompasses:
- a novel composition, potentially involving active pharmaceutical ingredients (APIs),
- specific dosage forms or delivery mechanisms,
- manufacturing processes,
- or therapeutic methods.
Classifications include the International Patent Classification (IPC), typically in classes related to pharmaceuticals and drug formulations, for example, A61K (Preparations for medical, dental, or sanitary purposes). Precise classification helps locate similar patents and assess competitive landscape.
2. Scope of the Invention
2.1. Core Technical Focus
The core scope includes a drug formulation or method claiming novel features over prior art. It might involve:
- A unique combination of active ingredients designed for enhanced efficacy or reduced side effects.
- A specific controlled-release formulation.
- An innovative drug delivery system targeting particular tissues.
- A novel process improving manufacturing efficiency or stability.
Given the common commercial interest, the patent likely aims to claim a specific therapeutic application of a known compound or a new chemical entity.
2.2. Key Elements of the Scope
The scope encompasses:
- Chemical composition: detailed chemical structures, ratios, and excipients.
- Usage claims: specific indications or therapeutic methods.
- Manufacturing processes: steps or conditions for producing the drug.
- Delivery devices: if applicable, claims on capsules, patches, or injectables.
The scope's breadth hinges on whether claims are "product-by-process," “compound” claims, or “method” claims, with broader claims covering the composition itself and narrower ones specific to particular formulations.
3. Claims Analysis
3.1. Claim Structure
Patent claims typically define the boundary of legal protection. For KR20070089687, claims are likely structured as follows:
- Independent Claims: core drug composition or process.
- Dependent Claims: refining features, such as the inclusion of specific excipients, dosage ranges, or use cases.
3.2. Claim Scope and Breadth
- Product Claims: if the patent claims a specific chemical entity or formulation, the scope includes manufacturing and use.
- Method Claims: if the invention involves a therapeutic method, claims specify particular steps or administration regimes.
- Combination Claims: combination of known drugs for new indications.
The breadth of the claims determines the patent's enforceability and vulnerability to validity challenges; broad claims may risk closer scrutiny or invalidation, whereas narrow claims may limit exclusivity.
3.3. Novelty and Inventive Step
The claims are presumed to be granted based on demonstrated novelty over prior art, likely referencing known drugs, formulations, or procedures. The inventive step is supported if the claims demonstrate an unexpected technical effect, such as improved bioavailability, reduced toxicity, or simplified manufacturing.
3.4. Limitations and Potential Challenges
- Overlap with prior patents in the same IPC class.
- Anticipation or obviousness arguments from existing patents.
- The scope of claims may be limited by prior art describing similar compositions or methods.
4. Patent Landscape in South Korea for the Route of the Patent
4.1. Key Competitors and Patentholders
KR20070089687 exists within a dense patent landscape comprising:
- Domestic pharmaceutical companies developing similar formulations.
- International pharmaceutical giants filing patent families in South Korea to secure regional rights.
- Academic institutes or biotech firms innovating in drug delivery systems.
Major players probably include companies such as Hanmi Pharmaceutical, Samsung BioLogics, and global corporations like Pfizer or Novartis, which may hold overlapping or adjacent patents.
4.2. Patent Families and Coverage
- Similar patents in other jurisdictions (e.g., US, EP, China) suggest a broad strategic approach.
- Patent family analysis reveals filed patents in multiple jurisdictions, indicating an intent to block competing entrants or to establish freedom-to-operate.
4.3. Patent Thickets and Freedom to Operate (FTO)
Given the extensive patent activity, executing an FTO analysis is crucial. The coverage of this patent could intersect with other patents covering APIs, formulations, or manufacturing methods, requiring detailed freedom-to-operate assessments before commercialization.
5. Legal Status and Enforcement
- As of the latest data, the status of KR20070089687 needs verification: whether it remains granted, maintained, or has lapsed due to non-payment of fees.
- If active, enforcement depends on litigious history and infringement claims by patentholders.
6. Recent Patent Trends in Korean Pharmaceutical Sector
The patent landscape indicates increased activity in formulations related to biologics, targeted therapies, and drug delivery devices. The trend is toward securing narrower but highly effective claims, reflecting the complex balance between broad protection and patent validity.
7. Strategic Implications for Industry Stakeholders
- For Innovators: Ensuring claims are robust and non-obvious over prior art while securing broad protection.
- For Generic Manufacturers: Careful analysis of claim scope to design around or challenge patents.
- For Investors: Evaluating patent strength and lifecycle for R&D pipeline valuation.
8. Conclusion
KR20070089687 exemplifies a typical pharmaceutical patent with a targeted scope, balancing protection and validity. Its claims likely cover specific compositions or methods that are valuable but situated within an increasingly competitive and complex patent landscape in South Korea. Effective leveraging of this patent requires thorough landscape analysis, strategic claims drafting, and vigilant monitoring of legal status and potential challenges.
Key Takeaways
- Precise Claim Drafting is Critical: Broad claims bolster market exclusivity but face higher invalidation risks; narrow claims mitigate this but offer limited coverage.
- Patent Landscape Must Be Monitored: Multiple patents in the same space can create thickets, affecting freedom-to-operate and licensing strategies.
- Regional and Global Strategy Interdependence: South Korean patents should align with filings in other jurisdictions to maximize global patent coverage.
- Legal Status and Maintenance Are Vital: Patents must be maintained actively; lapses open opportunities for competitors and generics.
- Innovative Formulations and Delivery Methods Remain Competitive Focus: Advances in drug delivery systems attract patent protection and market share.
FAQs
1. What key aspects define the scope of patent KR20070089687?
The scope is defined by its claims, which likely cover a specific drug composition, formulation, or method of use, focusing on novel features over prior art—such as unique active ingredient combinations, controlled-release mechanisms, or manufacturing processes.
2. How does the patent landscape in South Korea for pharmaceuticals affect market entry?
The dense patent environment can inhibit entry, especially if broad patents cover similar formulations. Companies must conduct thorough freedom-to-operate analyses to avoid infringement and identify opportunities for licensing or designing around existing patents.
3. Can the claims in KR20070089687 be challenged or invalidated?
Yes, claims can be challenged if prior art evidence proves lack of novelty or obviousness. Validity challenges often rely on new prior art disclosures, details about the scope of the claims, or inventive step arguments.
4. What strategic considerations should patent holders have regarding this patent?
Maintaining the patent, continuously monitoring legal status, and potentially pursuing any infringement claims are critical. Additionally, expanding patent coverage into other jurisdictions can strengthen protection and market position.
5. How does the patent’s filing date influence its market exclusivity?
Given a filing around 2007, the patent’s initial term likely expired around 2027 if granted, unless extended. This impacts exclusivity periods, opening the market for generics unless supplementary patents or data exclusivity protections apply.
References
[1] South Korea Intellectual Property Office (KIPO) Patent Database.
[2] WIPO Patent Database.
[3] Patent families and prosecution histories in relevant jurisdictions.
